Active Ingredient: GIVOSIRAN SODIUM
Proprietary Name: GIVLAARI
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 189MG BASE/ML (EQ 189MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212194
Product Number: 001
Approval Date: Nov 20, 2019
Applicant Holder Full Name: ALNYLAM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information